Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Nov 5, 2025-- Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the third quarter ended September 30, 2025. "Our third quarter demonstrated exceptional execution …